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Secrets of the Cutaneous Basement
Membrane
Sarolta Karpati1
The paper in this issue by Has and co-workers reports 15 non-Herlitz epidermo-
lysis bullosa patients with the same single amino-acid substitution in collagen XVII,
all of whom presented with clinical and pathological features resembling Kindler
syndrome. Here we consider why and how a hemidesmosomal pathology can
mimic a focal adhesion bond disease, both clinically and ultrastructurally.
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In this issue of JID, Cristina Has and an
international group of specialists on
epidermolysis bullosa (EB) report on a
substitution mutation of collagen XVII
that is associated with several un-
expected skin and mucosal features
that are ordinarily not observed in
patients with junctional EB other (non-
Herlitz-type junctional EB) disease. The
authors also find a clinical overlap with
another inherited EB, the Kindler syn-
drome. Furthermore, the clinical fea-
tures developed rather late, years and
even decades after birth in most of
the patients, indicating a long-lasting
mechanism of functional compensation
and slow progression of the inherited
basement membrane (BM) damage.
Structural stability and dynamics
of collagen XVII within the
hemidesmosomal anchoring complex
The collagen XVII (180 kDa) was identi-
fied within the cutaneous basement
membrane zone (BMZ) chronologically
as the second, and functionally as the
major, autoantigen of bullous pemphi-
goid (BP), and therefore it has also been
called BPAG2 (BP antigen 2) or BP180.
The final product is a trimer of three
180 kDa a1 XVII chains [a1(XVII)3], and
it anchors basal keratinocytes at the
hemidesmosomal plaque through the
lamina lucida to the lamina densa of
the BM. Its intracellular N-terminal
domain contributes to hemidesmosomal
plaque stability, and it interacts with the
plaque proteins plectin and BPAG1
(BP230) and also with the intracellular
tail of b4 integrin. The 120 kDa extra-
cellular, flexible, collagenous ectodo-
main of the molecule is part of the
anchoring filament and, while binding
to the a6 integrin and laminin 332,
crosses the lamina lucida of the BM
where it anchors the lamina densa. This
ectodomain contains 15 collagenous
subdomains separated by 16 non-col-
lagenous (NC) interruptions (Birk and
Bruckner, 2011).
The 120 kDa ectodomain is shed from
the 180 kDa transmembrane mole-
cule at the external surface of basal
keratinocytes within the NC16 domain
by metalloproteinases of the ADAM
(A Disintegrin And Metalloproteinase)
family, predominantly by the tumor
necrosis factor-converting enzyme
(TACE alias ADAM 17) or by ADAM 9
or ADAM 10. The shed ecto-collagen
XVII functions as a ‘‘mobile’’ compo-
nent of the extracellular matrix (ECM); it
is present not only in the lamina lucida
but also in the uppermost dermal con-
nective tissue. The ectodomain acquires
new epitopes through proteolytic clea-
vage, which identify and distinguish the
cleaved molecules from the uncleaved
180 kDa protein. There are also smaller
shed ectodomains (e.g., 95 kDa) with
distinct cleavage sites and neoepitopes.
Neoepitopes within the NC16A domain
are recognized preferentially in auto-
immune blistering diseases such as BP,
pemphigoid gestationis, and the linear
IgA dermatosis (Nishie et al., 2010).
Ectodomain shedding weakens basal
keratinocyte binding to the underlying
BM when the architectural stability of the
molecule is disrupted. Shedding may be
of physiological importance during the
differentiation of the basal keratinocytes,
as well as in their movement during
wound healing and tissue regeneration
(Hashmi and Marinkovich, 2011).
Cross-talk along the BMZ: the key role
of b-integrins in adhesome interactions
The bidirectional interaction between cells
and their environment is mediated predo-
minantly via integrins that accumulate in
adhesomes. There are collagen-, laminin-,
and leukocyte-binding integrins. The abil-
ity of integrins to be activated and to
initiate signaling pathways depends upon
the type of adhesion complexes that are
formed between cells and the ECM. Acti-
vated integrins become clustered and form
dynamic integrin adhesomes, which are
‘‘signaling points’’ (Schiller and Fa¨ssler,
2013). Proteins that bind the intra-
cellular domain of b-integrins are able to
activate these b-integrins and to increase
their adhesion to the ECM. b1 integrins,
the largest integrin subfamily, are usually
involved in cell migration, proliferation,
and differentiation, and they participate
in development, tissue homeostasis,
and tumor progression. Integrin-targeted
biological therapies can be very effective
tools for tumor suppression (Marelli et al.,
2013).
Recent studies have demonstrated
how in genetically engineered cells diff-
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erent integrins can cooperate to modu-
late the signaling pathways that are
required for adhesion morphology,
cytoskeleton distribution, cell contracti-
lity, and rigidity sensing of the ECM.
Integrin classes have been shown to
be capable of forming unique signaling
centers consisting of adaptor and signal-
ing molecules. These are able to initiate
distinct signaling pathways, and thus
cells can ultimately translate even
mechanical signals into biochemical
changes (Schiller et al., 2013).
a3b1 Integrins and kindlins in focal
adhesions
Focal adhesions of the basal keratino-
cytes are formed primarily along a core
of transmembrane a3b1 integrins that
connect the actin cytoskeleton to the
BMZ and serve as adhesion receptors in
bidirectional ECM–cell interactions.
These adhesomes may incorporate
more than 100 different proteins around
the dynamically formed group of a3b1
heterodimers. These integrins, as
transmembrane bidirectional signaling
molecules, transduce extracellular sig-
nals into cells upon extracellular ligand
binding, and, by recruiting signaling
and adaptor proteins to their intra-
cellular tails, they initiate actin reorga-
nization and intracellular signaling
pathways. Kindlins are a family of
cytoplasmic adaptor proteins localized
adjacent to focal adhesions (Meves
et al., 2009). All kindlins contain a
central FERM domain (band 4.1, ezrin,
radixin, moesin), and they are able to
bind and activate b-integrins and
participate in cell–matrix cross-talk via
in–out and out–in signaling. In the skin,
Kindlin-1 is present along the focal
adhesions of the dermo–epidermal
junction where they bind to the cyto-
plasmic tails of b1- and b3-integrins.
Mutations in the Kindlin-1 (FERMT1)
gene have been found to cause the
Kindler syndrome, a type of EB disease
(Bruckner-Tuderman and Has, 2013).
a6b4 Integrins in hemidesmosomes
Collagen XVII binds the cytoplasmic
tail of b4 integrin and, indirectly through
the hemidesmosomal plaque proteins
(plectin and BP230) to the keratin fila-
ment network. Collagen XVII and a6
integrins interact with each other and
with laminin 332 within the BM.
Mutations in collagen XVII, laminin
332, and integrin a6b4 induce a hetero-
genous group of inherited skin fragility
diseases called junctional EB other
(Kiritsi et al., 2013).
Disturbed signaling and cell adhesion in
collagen XVII pathologies
 In vitro studies using collagen XVII-
deficient and -sufficient epidermal
keratinocyte cultures suggest that this
transmembrane collagen may have a
central role in the initiation of epithe-
lial inflammatory responses (Van den
Bergh et al., 2012).
 The role of the ADAM family in
collagen XVII shedding also suggests
direct and/or indirect contributions
of BPAG2 to cell–matrix signaling.
These proteinases generally initiate
cell migration and ligand–receptor
interactions: ADAMs also mediate
ectodomain shedding initiated by
cytokines and their receptors, and they
regulate signaling during inflam-
matory responses via tumor necrosis
factor, IL-6, and EGF receptors and
Notch (Khokha et al., 2013).
 Extracellular phosphorylation repre-
sents a novel way of regulating
cell adhesion, cell proliferation, and
immune responses. Extracellular phos-
phorylation of collagen XVII by ecto-
casein-kinase 2 inhibits the ectodo-
main shedding by TACE and, through
that, it modifies adhesion and motility
(Zimina et al., 2007).
 Recently, transmembrane collagens
were identified in the brain as active
molecules with dynamic functions
during neuronal and synaptic differ-
entiation, axonal outgrowth, and brain
development. The presence of and
autoantibody binding to brain col-
lagen XVII was correlated with
enhanced CNS pathology in patients
with BP (Seppa¨nen, 2013).
The story of the arginine–glutamine
substitution COL17A1 p.R1303Q and
the pathological reorganization of the
cutaneous BMZ
The cutaneous BMZ is a highly complex
suprastructure functioning between the
epidermis and the dermis as a static
bridge that provides resistance against
mechanical forces and as a dynamic
connection that provides tools for
bilateral cross-talk, signaling, and
cellular trafficking between the ECM
and basal keratinocytes (Hashmi and
Marinkovich, 2011; Tsuruta et al.,
2011). Laminin 332 is thought to be a
supramolecular bridge communicating
with the integrins a6b4 at hemidesmo-
somes and also with a3b1 integrins
within the focal adhesions (Kiritsi
et al., 2013). The base of the BMZ
suprastructure is built primarily from
two networks superimposed and wel-
ded together by perlecan: the laminin
332 network in the lamina lucida and
the collagen IV network within the
lamina densa (Behrens et al., 2012).
The COL17A1p.R1303Q hemidesmo-
some-anchoring filament complex-
bound mutation is interesting as it seems
to disturb adhesive BMZ activities only
modestly (for years as compensated
Clinical Implications
 A rare form of junctional epidermolysis bullosa presented with clinical
symptoms resembling Kindler syndrome occurs in patients carrying the
p.R1303Q mutation of collagen XVII.
 This arginine–glutamine substitution seems to induce a functional damage
in the basement membrane and in the underlying extracellular matrix,
causing slowly progressive structural changes manifested as atrophy,
scarring or acral sclerodermiform changes, loss of dermatoglyphs, nail
dystrophy, and mild skin fragility with variable mucosal involvement.
 An international group of specialists collected clinical, ultrastructural, and
antigen mapping data on the skin from 15 patients carrying this mutation.
 The pathological significance of the new glutamine in the non-collagenous
extracellular domain of collagen XVII remains unclear, however.
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mild skin fragility), but it appears to
extend the effects to the functions of
focal adhesions (to begin resembling
Kindler’s disease). Furthermore, this
mutation progressively reorganizes the
ultrastructure of the BMZ, as indicated
by the loss of hemidesmosomes and
the loss of lamina lucida, while the
anchoring fibrils become covered with
an amorphous material. Laminin 2,
collagen IV, and collagen VII staining
showed a broad and irregular distri-
bution along the BMZ and within the
underlying papillary dermis.
The authors speculate that the
R1303Q mutation, with a new gluta-
mine residue at the extracellular
NC domain 4 of collagen XVII, might
be a new binding site for tissue trans-
glutaminase (TG2), an enzyme involved
in connective tissue cross-linking (Lai
and Greenberg, 2013). The observation
that in patients with the R1303Q muta-
tion both TG2 and tenascin C showed a
pathological distribution along and
under the BMZ supports this hypothesis.
Conclusion
The cause of R1303Q-induced pathol-
ogy remains uncertain, but it is definitely
of considerable interest. The very com-
plex BMZ unit tends to keep its secrets,
but the paper by Has et al. (2014) now
shows us how important new infor-
mation can be gained about this supra-
molecular system by careful phenotype
analysis of related diseases. On the other
hand, there is still much to be done.
Has et al. now show how
new knowledge on the
BMZ arose from careful
analyses of disease
phenotype.
Several of the questions summarized
by Fa¨ssler and his group recently as
‘‘tasks’’ for ECM researchers include the
following (Schiller and Fa¨ssler, 2013):
Adhesome interactions—how is the
formation of a cell–matrix adhesion
initiated?
What are the dynamics of protein–
protein interactions at cell–matrix adhe-
sion sites, and what is the structure
of these supramolecular assemblies?
Mechanotransduction—how is mecha-
nical force translated into biochemical
signals at cell–matrix adhesions? How
are signals from cell–matrix adhesions
spatially propagated to the cytoskeleton?
How does mechanical tension trigger the
recruitment of proteins to cell–matrix
adhesion sites?
Signaling, specificity, and diversity—
how diverse is cell–matrix adhesion
signaling in different cell types and
tissues? Which proteins of the adhesome
mediate integrin-subtype-specific func-
tions? What are the molecular mechan-
isms of integrin cross talk? Where and
how are integrin and growth factor
receptor signals combined?
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